U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information.
However, the collection of OMB before submitting the collection of information, according to the requirement, ACL is publishing a notice of the proposed collection of information set forth in this document.
The collection of information, ACL in which collection of information, ACL includes comments on our burden estimates or any other aspect of this collection of information.
(1) Whether the proposed collection of information is necessary for the proper performance of ACL's functions, including whether the information will be available.
(2) the accuracy of ACL's estimate of the burden of the proposed collection in提前, including the validity of the methodology and assumptions used to determine burden estimates;
(3) ways to enhance the quality, utility, and clarity of the information to the user;
(4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques when appropriate, and other forms of information technology.
The Administration for Community Living (ACL) is requesting approval for a revised data collection associated with the Evaluation of the Administration for the purpose of the evaluation of the Administration, Indian, Alaska Native, and Native Hawaiian Programs (Older Americans Act [OAA] Title VI; short title: Evaluation of the Title VI Programs). The evaluation of the Standards of Native Americans for nutrition services, supportive services, and family, caregiver support services. The purpose of Title VI is "to promote the delivery of supportive services, including the use of the program of the Administration, Alaskan Natives, and Native Hawaiians that are comparable to services provided under Title III" (42 U.S.C. 3057), which provides nutrition, caregiver and supportive services. Title VI is comprised of patients, Part A provides nutrition industries, preventive services to American Indians and Alaska Natives, Part B provides nutrition and supportive services to Native Hawaiians, and Part B provides nutrition and supportive services to Native Hawaiians, and Part B provides nutrition and supportive
<table border=1><tr>
<td>Respondent type</td>
<td>Form name</td>
<td>
<table>
<tr>
<td>Number of</td>
</tr>
<tr>
<td>annual</td>
</tr>
<tr>
<td>respondents</td>
</tr>
</table>
</td>
<td>
<table>
<tr>
<td>Number of</td>
</tr>
<tr>
<td>responses per</td>
</tr>
<tr>
<td>respondent</td>
</tr>
</table>
</td>
<td>
<table>
<tr>
<td>Average</td>
</tr>
<tr>
<td>burden</td>
</tr>
<tr>
<td>per response</td>
</tr>
</table>
</td>
<td>
<table>
<tr>
<td>Annual burden</td>
</tr>
<tr>
<td>hours</td>
</tr>
</table>
</td>
</tr>


<tr>
<td>Program director</td>
<td>Program staff interview guide</td>
<td></td>
<td>12</td>
<td></td>
<td>12</td>
</tr>
<tr>
<td>Program director</td>
<td>Program staff focus group moderator guide</td>
<td>$\ldots$</td>
<td>12</td>
<td>1</td>
<td>24</td>
</tr>
<tr>
<td>Program director</td>
<td>Program staff follow-up interview guide</td>
<td>$\ldots$</td>
<td>12</td>
<td>1</td>
<td>12</td>
</tr>
<tr>
<td>Other Program Staff</td>
<td>Tribal program staff interview guide</td>
<td>$\ldots$</td>
<td>12</td>
<td>1</td>
<td>12</td>
</tr>
</table>Dated: May 12, 2020.
Mary Lazare,
Principal Deputy Administrator.
(FR Doc. 2020-10671 Filed 5-18-20, 8:45 am)
BILLING CODE 4134-01-P
\section*{DEPARTMENT OF HEALTH AND}
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2020-D-1370]
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry; Availability
AGENCY: Food and Drug Administration, HIS.
ACTION: Notice of availability.
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "COVID19: Developing Drugs and Biological Products for Treatment or Prevention." This guidance describes FDA's current recommendations regarding phase 2 or phase 3 trials for drugs or biological drugs; and the development for the treatment order development for the treatment order. Given the public health emergency presented by COVID-19, this guidance document is being implemented without prior public comment because FDA has determined that prior public participation is not feasible or appropriate, but it remains subject to services to Native Hawaiians, and Part C provides caregiver services to any programs that have Part A/B.
The evaluation will consist of six data collection activities: (1) Tribal program staff interviews; (2) tribal program staff focus groups; (3) tribal elder focus groups; (4) tribal elder education; (5) tribal caregiver focus groups, and (6) follow-up tribal program staff interview. ACL is requesting to revise the currently approved data collection under OMB 0985-0059 by removing the tribal program staff interview. The tribal program staff interview. proposed revisions also include removing annual performance reporting data elements from the currently approved IIC under OMB 0985-0059 to the OMB approved Title VI Annual Committee and our OMB 0985-0059 for review and comment on this proposed information collection requests; please visit the ACL website (https://www.acl.gov/about.acl/public/ info)
Estimated Program Burden: AEC estimates the burden associated with this collection of information as follows:
comment in accordance with the Agency's good guidance practices.
DATES: The announcement of the guidance is published in the Federal Register on May 19, 2020. The guidance is also current is immediately in effect, but it is difficult to be expected to comment in accordance with the Agency's good guidance practices.
ADDRESSES: You may submit electronic or written comments on Agency guides and any time as follows:
Electronic Submissions
Submit electronic comments in the following way:
- Federal eTulemaking Portal:
https://www.regulations.gov. Follow the instructions for submitting comments.
Comments submitted electronically,